Upon ingestion, the new Enzian dosage form resides in the stomach for several hours and steadily delivers drug into the blood. This enables enhanced effectiveness of many life-saving drug therapies.

BOSTON--(BUSINESS WIRE)--PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company, noted that its Founded ...

Lipid-based drug delivery systems encompass a range of formulations in which therapeutic agents are incorporated into or associated with lipid components to improve solubility, stability and ...

Nanoparticle drug delivery systems encompass a versatile suite of carriers engineered to improve the absorption, distribution and therapeutic impact of active pharmaceutical ingredients. By ...

The US Food and Drug Administration (FDA) on Monday published two new draft guidance documents providing recommendations to sponsors planning to conduct food-effect (FE) studies for orally ...

The effectiveness of any drug molecule depends on how well it interacts with the internal environment inside our body. Its pharmacokinetic (PK) properties determine how successfully it escapes ...

In this interview, Karl Box discusses how particle drift analysis using flux tools improves oral drug absorption in pharmaceutical research. Can you tell us about Pion’s Rainbow Dynamic Dissolution ...

Detailed price information for Northwest Biothrputcs Inc (NWBO) from The Globe and Mail including charting and trades.

The US Food and Drug Administration (FDA) has published a new draft guidance recommending various approaches when conducting bioequivalence (BE) and bioavailability (BA) studies in support of new and ...

Preclinical data demonstrate enhanced systemic exposure and bioavailability, reduced dermal toxicity, and improved safety profile in ALT-B4-enabled ADC therapy DAEJEON, South Korea, June 10, 2026 ...

Biotechnology organizations are turning in growing numbers to alternative strategies centered on strengthening the performance of already-approved drugs. Oncotelic Therapeutics is developing ...